Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valens Company Inc (The) Ordinary Shares VLNCF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada... see more

Recent & Breaking News (OTCQX:VLNCF)

SNDL Completes Acquisition of The Valens Company

PR Newswire January 17, 2023

THE VALENS COMPANY OBTAINS FINAL COURT ORDER APPROVING THE PROPOSED PLAN OF ARRANGEMENT WITH SNDL

PR Newswire January 3, 2023

The Valens Company Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

PR Newswire December 13, 2022

Valens Shareholders Vote in Favour of the Arrangement with SNDL

PR Newswire November 29, 2022

BOTH LEADING INDEPENDENT PROXY ADVISORS RECOMMEND SHAREHOLDERS OF THE VALENS COMPANY INC. VOTE FOR THE PROPOSED ARRANGEMENT WITH SNDL INC.

PR Newswire November 22, 2022

Valens Secures Sales Licence for Greater Toronto Area Beverage Facility

PR Newswire November 2, 2022

THE VALENS COMPANY ANNOUNCES MAILING AND FILING OF CIRCULAR FOR SPECIAL MEETING OF SHAREHOLDERS TO APPROVE ARRANGEMENT WITH SNDL INC.

PR Newswire October 27, 2022

The Valens Company Reports Third Quarter Fiscal 2022 Financial Results

PR Newswire October 13, 2022

The Valens Company to Release Financial Results for the Third Quarter of 2022

PR Newswire October 6, 2022

IIROC Trade Resumption - VLNS

Canada NewsWire August 22, 2022

SNDL Announces Agreement to Acquire The Valens Company to Create Leading Vertically Integrated Cannabis Platform

PR Newswire August 22, 2022

IIROC Trading Halt - VLNS

Canada NewsWire August 22, 2022

The Valens Company Announces Results of Annual General Meeting of Shareholders

PR Newswire August 3, 2022

The Valens Company Announces Nomination of Independent Director to Board of Directors

PR Newswire July 19, 2022

The Valens Company Reports Second Quarter Fiscal 2022 Financial Results

PR Newswire July 13, 2022

The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2022

PR Newswire July 6, 2022

The Valens Company Signs Exclusive Cannabis Partnership with Coldhaus Distribution

PR Newswire June 22, 2022

The Valens Company Receives Additional Product Listings with SQDC & Introduces Bon Jak an Exclusive Cannabis Brand in Quebec

PR Newswire June 16, 2022

The Valens Company Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

PR Newswire June 15, 2022

The Valens Company to Participate in Upcoming June Investor Conferences

PR Newswire June 2, 2022